Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Barr Prozac Appeal Claims Lilly Double Patenting; Seeks Patent Invalidation

Executive Summary

Barr is focusing its appellate challenge of the Prozac patent ruling on double patent claims.

You may also be interested in...



Bristol's Taxol Appeal Emphasizes Contribution Of Improved Dosing Regimen

Bristol-Myers Squibb's Taxol patent appeal hinges in part on the company's arguments that it should receive a reward for bringing an improved dosing schedule for paclitaxel to the public.

Bristol's Taxol Appeal Emphasizes Contribution Of Improved Dosing Regimen

Bristol-Myers Squibb's Taxol patent appeal hinges in part on the company's arguments that it should receive a reward for bringing an improved dosing schedule for paclitaxel to the public.

Lilly, Barr Expect Prozac Generics In August 2001 After Appeals Court Ruling

Lilly and Barr expect generic competition to Prozac to arrive in August 2001 after an Aug. 9 Washington D.C. federal appeals court decision in favor of Barr's challenge of a fluoxetine patent.

Related Content

UsernamePublicRestriction

Register

MT142464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel